Tks. Whats your take on Shilpa results, competitive intensity in US & other countries,Shilpa relationship with distributors in US?
Seems Jadcherla formulation plant inspection has gone through with zero observations recently. What could be its impact?
Are there headwinds for specialized Onco players like Shilpa as well or they are comparatively better off?